バイオプロセス技術の市場規模と2028年までの予測- タイプ別、モダリティ別、エンドユーザー別の世界分析

バイオプロセス技術の市場規模は、2022年の308億9,000万米ドルから2028年には770億9,000万米ドルに成長すると予測されています。2022年から2028年までのCAGRは16.8%を記録すると推定されます。

バイオプロセス技術の世界市場成長の主な原動力は、新薬化合物の導入に向けた研究開発費の増加と慢性疾患の蔓延です。しかし、厳しい規制政策が市場成長の妨げとなっています。

バイオプロセス技術は、人類に利益をもたらす生物学的工場として機能する、微細な生命を利用する技術です。バイオプロセス技術では、微生物は砂糖やパーム油工場廃棄物などの基質と飼料からなる制御された環境で培養されます。これらの原料は、タンパク質、プラットフォーム化学物質、脂質などの商業的に有用な生物学的成分に変化します。また、円滑な知識の移転と最適なプロセスの再現性を確保するためには、バイオプロセスの技術移転が重要な役割を果たします。

アジア太平洋地域は、バイオプロセス技術市場シェアで最も速いCAGRの成長を記録しています。アジア太平洋地域の中では、中国が2022-2028年のバイオプロセス技術市場で大きなシェアを占めています。さらに、インドは2022-2028年の予測期間中、バイオプロセス技術市場のCAGRが21.3%と大幅に上昇します。インドはバイオプロセスのアウトソーシング先として知られ、医薬品有効成分（API）や原材料の主要な供給国となっています。また、インドのバイオプロセス能力は、有能な労働力とコスト効率に大きく依存しており、市場の成長機会を生み出しています。また、低分子医薬品製造はインドの製薬・バイオ企業の強みです。低分子医薬品はジェネリック医薬品とみなされ、米国や欧州などの国際市場で広く認知されています。

さらに、インドには細胞治療や遺伝子治療のバイオシミラーの開発に携わるアーリーステージの起業家がおり、さまざまなトップ企業が国内で革新的な製品の発売を発表しています。2022年5月、フロイデンベルグ・メディカルはインドで新製品「HeliFlex」の発売を発表しました。同製品は高純度の熱可塑性エラストマーTPEチューブで、バイオ医薬品の流体移送用途に有用なよう設計されています。このTPEチューブは、既存のチューブラインに溶接してヒートシールすることができるため、医薬品バイオプロセス・アプリケーションに最適で、バイオ医薬品プロセスでの迅速、安全、容易な流体輸送を可能にします。

バイオプロセス技術市場は北米が最大シェアを占めています。この地域におけるバイオプロセス技術市場の成長は、革新的な製品（特にバイオプロセス技術関連）を発売する大手企業の存在、同地域における製品導入の増加、バイオプロセス技術の技術的進歩によるものです。北米では、米国がバイオプロセス技術の最大シェアを記録しています。食品医薬品局（FDA）の報告書によると、米国では3,000万人以上が7,000以上の希少疾病に苦しんでおり、治療の選択肢が少なく、生命を脅かす状況にあります。希少疾患の治療における医薬品、生物学的製剤、デバイスの開発は、希少疾患の歴史が理解されておらず、臨床試験の実施が困難であるため、困難が伴う。そのため、遺伝子・細胞治療（CGT）や特殊医薬品などのバイオプロセス技術の成長は、希少疾患の治療における根本的な転換を意味します。例えば、CGTは希少疾患の治療において、製剤化された医薬品よりも大きな健康上の利点を明らかにしています。米国では、遺伝子治療薬を対象とした治験薬（IND）申請が900件以上進行中です。また、毎年10～20の遺伝子治療薬がFDAによって承認されています。同様に2022年8月、FDAはBluebird Bio社の"ジンテグロ（ベチベグロジェン・オートテムセル）"を承認しました。これは、希少な神経疾患である脳性副腎白質ジストロフィー（CALD）の治療を目的とした、米国で最も高額な単剤承認でした。

自動リアルタイム・フローサイトメトリー（ART-FCM）の出現

フローサイトメトリー（FCM）とその技術的可能性は、バイオリアクター内の様々なタイプの細胞の単一細胞特性や集団分布の解析ツールとして、過去10年間に大きく進歩しました。その過程で、オペレーターの干渉を受けずにバイオリアクターのプロセスをサンプリング頻度を変えながら長期間モニタリングするための自動リアルタイムフローサイトメトリー（ART-FCM）ソリューションがいくつか開発されました。

ART-FCMは、バイオプロセスにおける重要なイベントを見逃すことなく長期間の測定を可能にし、未知の可能性が高く、より詳細に調査されるべき時間的現象を発見します。また、より頻繁な測定も、人員の都合に左右されることなく、ユーザーが定義した頻度で行うことができます。オミクスのような単一細胞レベルでは部分的にしか利用できない手法と比較すると、ART-FCMを利用することで、労力と時間を費やすことなく、マルチパラメーター測定を容易に確立することができます。

従来のFCM研究と比較して、マイクロ流体デバイスはチップ上のART-FCMとして大きな将来性を持っています。この文脈では、異なるバイオリアクターまたはバイオリアクターセットアップ内の異なる場所からのサンプルを同時に分析できるため、並列化がより重要になるかもしれないです。また、蛍光プロセスパラメーターの高速で再現性の高いリアルタイムモニタリングが求められる他の実験セットアップにも、多くの側面が適応できるかもしれないです。結論として、ART-FCMは今後おそらく飛躍的に進歩すると思われます。

COVID-19パンデミックはバイオプロセス技術市場に好影響を与えました。5月中旬までに、COVID-19治療用に215以上の新規および再利用治療薬がパイプラインに並び、疫病対策イノベーション連合やメリンダ＆ゲイツ財団などの組織からの投資が増加しました。また、バイオ製薬会社による商業生産のための追加投資も行われました。パンデミックの中、この投資によってバイオプロセス技術の導入が進み、大規模な効率性と生産性が向上しました。さらに、地域市場においてインフラ施設が整備され、最終的にはこの地域におけるサプライチェーンとバイオプロセス施設に向けて加速することになります。

タイプ別洞察

バイオプロセス技術市場は、タイプ別に細胞培養培地バイオプロセス、クロマトグラフィーバイオプロセス、消耗品・付属品、その他に区分されます。細胞培養培地バイオプロセス分野は2022年にバイオプロセス技術の最大市場シェアを占めたが、クロマトグラフィバイオプロセスは予測期間（2023-2028年）に最も高いCAGRを記録すると予測されています。

モダリティベースの洞察

モダリティに基づくと、世界のバイオプロセス技術市場はシングルユースとマルチユースに二分されます。2022年のバイオプロセス技術の市場シェアは、シングルユース分野が大きいです。マルチユースセグメントは予測期間中、より高いCAGRで成長すると予測されています。

エンドユーザーに基づく洞察

エンドユーザー別では、バイオプロセス技術市場は学術・医療機関、バイオ医薬品企業、研究所、その他に分類されます。2022年にはバイオ製薬企業セグメントが最大の市場シェアを占めたが、学術・医療機関セグメントは予測期間中に高いCAGRを記録する見込みです。

バイオプロセス技術市場競合情勢と主な発展

Merck KGaA、Sartorius AG、Thermo Fisher Scientific Inc、Corning Inc、STAMM Biotech、Lonza Group AG、Eppendorf SE、Repligen Corp、Danaher Corp、BioPharma Dynamicsなどが、世界のバイオプロセス技術市場で事業を展開する主要企業です。大手企業は、市場でのプレゼンスと顧客層の拡大・多様化に注力し、ビジネスチャンスを獲得しています。

2022年6月、メルクはプロセス分析技術（PAT）を推進するため、アジレント・テクノロジーと提携しました。PATは世界の規制当局から強く奨励されており、リアルタイム・リリースとバイオプロセス4.0を実現する重要な要素です。

2020年3月、ザルトリウスはBIOSTAT STRジェネレーション3のシングルユース・バイオリアクターとBIOBRAINオートメーション・プラットフォームを発表し、バイオ医薬品のプロセス開発と製造の分野を変えるイノベーションを導入しました。バイオスタットSTRは生物製剤製造を簡素化します。

目次

第1章 イントロダクション

第2章 バイオプロセス技術市場：主な要点

第3章 調査手法

• 調査範囲
• 2次調査
• 1次調査

第4章 バイオプロセス技術市場：市場情勢

• PEST分析
  • 北米PEST分析
  • 欧州PEST分析
  • アジア太平洋PEST分析
  • 中南米PEST分析
  • 中東・アフリカPEST分析
• 専門家の見解

第5章 バイオプロセス技術市場：主要な市場力学

• 市場促進要因
  • 新薬開発のための研究開発費の増加
  • 慢性疾患の増加
• 市場抑制要因
  • 厳しい規制政策
• 市場機会
  • 先進バイオプロセス技術の導入
• 今後の動向
  • 自動リアルタイムフローサイトメトリー（ART-FCM）のイントロダクション
• 影響分析

第6章 バイオプロセス技術市場の世界分析

• バイオプロセス技術の世界市場収益と予測・分析
• バイオプロセス技術の世界市場：地域別予測・分析
• 主要プレイヤーの市場ポジショニング

第7章 バイオプロセス技術の世界市場：2028年までの収益と予測：タイプ別

• バイオプロセス技術市場収益シェア、タイプ別、2022年・2028年（%）
• 細胞培養液バイオプロセス
• クロマトグラフィーバイオプロセス
• 消耗品・アクセサリー
• その他

第8章 バイオプロセス技術の世界市場：2028 年までの分析と予測：モダリティ別

• バイオプロセス技術の世界市場：モダリティ別、2022年・2028年（%）
• シングルユース
• マルチユース

第9章 バイオプロセス技術の世界市場：2028年までの収益と予測：エンドユーザー別

• バイオプロセス技術の市場：2022年および2028年の売上高シェア、エンドユーザー別（%）
• 学術・医療機関
• バイオ医薬品企業
• 研究機関
• その他

第10章 バイオプロセス技術の世界市場：2028年までの収益と予測：地域別分析

• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン
  • その他欧州
• アジア太平洋
  • 中国
  • 日本
  • インド
  • 韓国
  • オーストラリア
  • その他アジア太平洋地域
• 中東・アフリカ
  • UAE
  • サウジアラビア
  • 南アフリカ
  • その他中東とアフリカ
• 中南米
  • ブラジル
  • アルゼンチン
  • その他中南米

第11章 COVID-19パンデミックのバイオプロセス技術市場へ与える影響

• 北米
• 欧州
• アジア太平洋
• 中東・アフリカ
• 中南米

第12章 バイオプロセス技術市場：業界情勢

• バイオプロセス技術市場における成長戦略
• 有機的成長戦略
• 無機的成長戦略

第13章 企業プロファイル

• Merck KGaA
• Sartorius AG
• Thermo Fisher Scientific Inc
• Corning Inc
• STAMM Biotech
• Lonza Group AG
• Eppendorf SE
• Repligen Corp
• Danaher Corp
• BioPharma Dynamics Ltd

第14章 付録

List Of Tables

• Table 1. R&D Investments by Major Pharmaceutical Companies
• Table 2. North America Bioprocess Technology Market, by Type - Revenue and Forecast to 2028 (US$ Million)
• Table 3. North America Bioprocess Technology Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
• Table 4. North America Bioprocess Technology Market, by End User - Revenue and Forecast to 2028 (US$ Million)
• Table 5. US Bioprocess Technology Market, by Type - Revenue and Forecast to 2028 (US$ Million)
• Table 6. US Bioprocess Technology Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
• Table 7. US Bioprocess Technology Market, by End User - Revenue and Forecast to 2028 (US$ Million)
• Table 8. Canada Bioprocess Technology Market, by Type - Revenue and Forecast to 2028 (US$ Million)
• Table 9. Canada Bioprocess Technology Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
• Table 10. Canada Bioprocess Technology Market, by End User - Revenue and Forecast to 2028 (US$ Million)
• Table 11. Mexico Bioprocess Technology Market, by Type - Revenue and Forecast to 2028 (US$ Million)
• Table 12. Mexico Bioprocess Technology Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
• Table 13. Mexico Bioprocess Technology Market, by End User - Revenue and Forecast to 2028 (US$ Million)
• Table 14. Europe Bioprocess Technology Market, by Type - Revenue and Forecast to 2028 (US$ Million)
• Table 15. Europe Bioprocess Technology Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
• Table 16. Europe Bioprocess Technology Market, by End User - Revenue and Forecast to 2028 (US$ Million)
• Table 17. Germany Bioprocess Technology Market, by Type - Revenue and Forecast to 2028 (US$ Million)
• Table 18. Germany Bioprocess Technology Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
• Table 19. Germany Bioprocess Technology Market, by End User - Revenue and Forecast to 2028 (US$ Million)
• Table 20. UK Bioprocess Technology Market, by Type - Revenue and Forecast to 2028 (US$ Million)
• Table 21. UK Bioprocess Technology Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
• Table 22. UK Bioprocess Technology Market, by End User - Revenue and Forecast to 2028 (US$ Million)
• Table 23. France Bioprocess Technology Market, by Type - Revenue and Forecast to 2028 (US$ Million)
• Table 24. France Bioprocess Technology Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
• Table 25. France Bioprocess Technology Market, by End User - Revenue and Forecast to 2028 (US$ Million)
• Table 26. Italy Bioprocess Technology Market, by Type - Revenue and Forecast to 2028 (US$ Million)
• Table 27. Italy Bioprocess Technology Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
• Table 28. Italy Bioprocess Technology Market, by End User - Revenue and Forecast to 2028 (US$ Million)
• Table 29. Spain Bioprocess Technology Market, by Type - Revenue and Forecast to 2028 (US$ Million)
• Table 30. Spain Bioprocess Technology Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
• Table 31. Spain Bioprocess Technology Market, by End User - Revenue and Forecast to 2028 (US$ Million)
• Table 32. Rest of Europe Bioprocess Technology Market, by Type - Revenue and Forecast to 2028 (US$ Million)
• Table 33. Rest of Europe Bioprocess Technology Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
• Table 34. Rest of Europe Bioprocess Technology Market, by End User - Revenue and Forecast to 2028 (US$ Million)
• Table 35. Asia Pacific Bioprocess Technology Market, by Type - Revenue and Forecast to 2028 (US$ Million)
• Table 36. Asia Pacific Bioprocess Technology Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
• Table 37. Asia Pacific Bioprocess Technology Market, by End User - Revenue and Forecast to 2028 (US$ Million)
• Table 38. China Bioprocess Technology Market, by Type - Revenue and Forecast to 2028 (US$ Million)
• Table 39. China Bioprocess Technology Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
• Table 40. China Bioprocess Technology Market, by End User - Revenue and Forecast to 2028 (US$ Million)
• Table 41. Japan Bioprocess Technology Market, by Type - Revenue and Forecast to 2028 (US$ Million)
• Table 42. Japan Bioprocess Technology Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
• Table 43. Japan Bioprocess Technology Market, by End User - Revenue and Forecast to 2028 (US$ Million)
• Table 44. India Bioprocess Technology Market, by Type - Revenue and Forecast to 2028 (US$ Million)
• Table 45. India Bioprocess Technology Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
• Table 46. India Bioprocess Technology Market, by End User - Revenue and Forecast to 2028 (US$ Million)
• Table 47. South Korea Bioprocess Technology Market, by Type - Revenue and Forecast to 2028 (US$ Million)
• Table 48. South Korea Bioprocess Technology Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
• Table 49. South Korea Bioprocess Technology Market, by End User - Revenue and Forecast to 2028 (US$ Million)
• Table 50. Australia Bioprocess Technology Market, by Type - Revenue and Forecast to 2028 (US$ Million)
• Table 51. Australia Bioprocess Technology Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
• Table 52. Australia Bioprocess Technology Market, by End User - Revenue and Forecast to 2028 (US$ Million)
• Table 53. Rest of Asia Pacific Bioprocess Technology Market, by Type - Revenue and Forecast to 2028 (US$ Million)
• Table 54. Rest of Asia Pacific Bioprocess Technology Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
• Table 55. Rest of Asia Pacific Bioprocess Technology Market, by End User - Revenue and Forecast to 2028 (US$ Million)
• Table 56. Middle East & Africa Bioprocess Technology Market, by Type - Revenue and Forecast to 2028 (US$ Million)
• Table 57. Middle East & Africa Bioprocess Technology Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
• Table 58. Middle East & Africa Bioprocess Technology Market, by End User - Revenue and Forecast to 2028 (US$ Million)
• Table 59. UAE Bioprocess Technology Market, by Type - Revenue and Forecast to 2028 (US$ Million)
• Table 60. UAE Bioprocess Technology Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
• Table 61. UAE Bioprocess Technology Market, by End User - Revenue and Forecast to 2028 (US$ Million)
• Table 62. Saudi Arabia Bioprocess Technology Market, by Type - Revenue and Forecast to 2028 (US$ Million)
• Table 63. Saudi Arabia Bioprocess Technology Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
• Table 64. Saudi Arabia Bioprocess Technology Market, by End User - Revenue and Forecast to 2028 (US$ Million)
• Table 65. South Africa Bioprocess Technology Market, by Type - Revenue and Forecast to 2028 (US$ Million)
• Table 66. South Africa Bioprocess Technology Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
• Table 67. South Africa Bioprocess Technology Market, by End User - Revenue and Forecast to 2028 (US$ Million)
• Table 68. Rest of Middle East & Africa Bioprocess Technology Market, by Type - Revenue and Forecast to 2028 (US$ Million)
• Table 69. Rest of Middle East & Africa Bioprocess Technology Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
• Table 70. Rest of Middle East & Africa Bioprocess Technology Market, by End User - Revenue and Forecast to 2028 (US$ Million)
• Table 71. South & Central America Bioprocess Technology Market, by Type - Revenue and Forecast to 2028 (US$ Million)
• Table 72. South & Central America Bioprocess Technology Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
• Table 73. South & Central America Bioprocess Technology Market, by End User - Revenue and Forecast to 2028 (US$ Million)
• Table 74. Brazil Bioprocess Technology Market, by Type - Revenue and Forecast to 2028 (US$ Million)
• Table 75. Brazil Bioprocess Technology Market, by Modality- Revenue and Forecast to 2028 (US$ Million)
• Table 76. Brazil Bioprocess Technology Market, by End User - Revenue and Forecast to 2028 (US$ Million)
• Table 77. Argentina Bioprocess Technology Market, by Type - Revenue and Forecast to 2028 (US$ Million)
• Table 78. Argentina Bioprocess Technology Market, by Modality- Revenue and Forecast to 2028 (US$ Million)
• Table 79. Argentina Bioprocess Technology Market, by End User - Revenue and Forecast to 2028 (US$ Million)
• Table 80. Rest of South & Central America Bioprocess Technology Market, by Type - Revenue and Forecast to 2028 (US$ Million)
• Table 81. Rest of South & Central America Bioprocess Technology Market, by Modality- Revenue and Forecast to 2028 (US$ Million)
• Table 82. Rest of South & Central America Bioprocess Technology Market, by End User - Revenue and Forecast to 2028 (US$ Million)
• Table 83. Recent Organic Growth Strategies in Bioprocess Technology Market
• Table 84. Recent Inorganic Growth Strategies in the Bioprocess Technology Market
• Table 85. Glossary of Terms

List Of Figures

• Figure 1. Bioprocess Technology Market Segmentation
• Figure 2. Bioprocess Technology Market, by Geography
• Figure 3. Global Bioprocess Technology Market Overview
• Figure 4. Consumables and Accessories Segment Held Largest Share of Type Segment in Bioprocess Technology Market
• Figure 5. Asia Pacific Expected to Show Remarkable Growth During Forecast Period
• Figure 6. Bioprocess Technology Market, by Geography (US$ Million)
• Figure 7. Global Bioprocess Technology Market - Leading Country Markets (US$ Million)
• Figure 8. Global Bioprocess Technology Market - Industry Landscape
• Figure 9. North America: PEST Analysis
• Figure 10. Europe: PEST Analysis
• Figure 11. Asia Pacific: PEST Analysis
• Figure 12. South & Central America: PEST Analysis
• Figure 13. Middle East & Africa: PEST Analysis
• Figure 14. Experts' Opinion
• Figure 15. Global Bioprocess Technology Market - Revenue Forecast and Analysis - 2020-2028
• Figure 16. Global Bioprocess Technology Market, by Geography - Forecast and Analysis (2022-2028)
• Figure 17. Market Positioning of Key Players in Bioprocess Technology Market
• Figure 18. Bioprocess Technology Market Revenue Share, by Type 2022 & 2028 (%)
• Figure 19. Cell Culture Media Bioprocess: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
• Figure 20. Chromatographic Bioprocess: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
• Figure 21. Consumables & Accessories: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
• Figure 22. Others: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
• Figure 23. Global Bioprocess Technology Market, by Modality 2022 & 2028 (%)
• Figure 24. Single Use: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
• Figure 25. Multiple Use: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
• Figure 26. Bioprocess Technology Market Revenue Share, by End User 2022 & 2028 (%)
• Figure 27. Academic & Medical Institutions: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
• Figure 28. Biopharmaceutical Companies: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
• Figure 29. Research Laboratories: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
• Figure 30. Others: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
• Figure 31. North America: Bioprocess Technology Market, by Key Country - Revenue (2022) (US$ Million)
• Figure 32. North America Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
• Figure 33. North America: Bioprocess Technology Market, by Country, 2022 & 2028 (%)
• Figure 34. US: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
• Figure 35. Canada: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
• Figure 36. Mexico: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
• Figure 37. Europe: Bioprocess Technology Market, by Key Country - Revenue (2022) (US$ Million)
• Figure 38. Europe Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
• Figure 39. Europe: Bioprocess Technology Market, by Country, 2022& 2028 (%)
• Figure 40. Germany: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
• Figure 41. UK: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
• Figure 42. France: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
• Figure 43. Italy: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
• Figure 44. Spain: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
• Figure 45. Rest of Europe: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
• Figure 46. Asia Pacific: Bioprocess Technology Market, by Key Country - Revenue (2022) (US$ Million)
• Figure 47. Asia Pacific Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
• Figure 48. China: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
• Figure 49. Japan: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
• Figure 50. India: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
• Figure 51. South Korea: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
• Figure 52. Australia: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
• Figure 53. Rest of Asia Pacific: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
• Figure 54. Middle East & Africa: Bioprocess Technology Market, by Key Country - Revenue (2022) (US$ Million)
• Figure 55. Middle East & Africa Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
• Figure 56. UAE: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
• Figure 57. Saudi Arabia: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
• Figure 58. South Africa: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
• Figure 59. Rest of Middle East & Africa: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
• Figure 60. South & Central America: Bioprocess Technology Market, by Key Country - Revenue (2022) (US$ Million)
• Figure 61. South & Central America Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
• Figure 62. South & Central America: Bioprocess Technology Market, by Country, 2022 & 2028 (%)
• Figure 63. Brazil: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
• Figure 64. Argentina: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
• Figure 65. Rest of South & Central America: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
• Figure 66. Impact of COVID-19 Pandemic on North American Country Markets
• Figure 67. Impact of COVID-19 Pandemic in European Country Markets
• Figure 68. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
• Figure 69. Impact of COVID-19 Pandemic in Middle East & Africa Country Markets
• Figure 70. Impact of COVID-19 Pandemic on South & Central American Country Markets
• Figure 71. Growth Strategies in Bioprocess Technology Market

The bioprocess technology market size is expected to grow from US$ 30.89 billion in 2022 to US$ 77.09 billion by 2028. The market is estimated to register a CAGR of 16.8% from 2022 to 2028.

The growth of the global bioprocess technology market growth is majorly driven by growing R&D spendings to introduce new drug compounds and increasing prevalence of chronic diseases. However, stringent regulatory policies hamper the market growth.

Bioprocess technology employs microscopic life, acting as a biological factory to benefit mankind. In bioprocess technology, microorganisms are grown in a controlled environment comprising feed with substrates such as sugar and palm oil mill waste. These ingredients transform to form commercially useful biological components such as proteins, platform chemicals, and lipids. Also, a well-executed bioprocess technology transfer plays a critical role in ensuring smooth knowledge transfer and optimal process reproducibility.

Asia Pacific region registers fastest growing CAGR for bioprocess technology market share. Among Asia Pacific region, China holds considerable share for bioprocess technology market during 2022-2028. Additionally, India will hold considerable CAGR of 21.3% for bioprocess technology market during the forecast period of 2022-2028. India is a well-known destination for bioprocess outsourcing, standing as a major supplier of active pharmaceutical ingredients (API) and raw materials. Also, India's bioprocessing capability is highly dependent on its qualified workforce and cost efficiencies, which creates growth opportunities for the market. Also, small molecule manufacturing is the strength of the pharma and biotechnology companies in the country. Small molecule pharmaceutical products are considered generics and well recognized across the international markets of the US, Europe, etc.

In addition, India comprises early-stage entrepreneurs involved in developing biosimilars in cell and gene therapy, and various top companies announced innovative product launches in the country. In May 2022, Freudenberg Medical announced the launch of a new product, "HeliFlex," in India. The product is a high-purity thermoplastic elastomer TPE tubing designed for utility in biopharmaceutical fluid transfer applications. The TPE tubing is ideal for pharmaceutical bioprocessing applications as it can be welded to existing tubing lines and heat-sealed, allowing fast, safe, and easy fluid transport in the biopharma process.

North America dominated the bioprocess technology market accounting maximum share. The bioprocess technology market growth in this region is attributed due to the presence of large players launching innovative products (particularly related to bioprocess technology), growing product introduction in the region, and technological advancements in bioprocess technology. In North America, the US records maximum share for the bioprocess technology. According to the Food and Drug Administration (FDA) report, over 30 million people in the US suffer from ~7,000 rare diseases, accounting for life-threatening conditions with low treatment options. Drug, biological, and device development in the treatment of rare diseases is challenging due to a lack of understanding of the history of rare diseases and difficulty in conducting clinical trials. Therefore, the growth of bioprocess technologies such as gene and cell therapies (CGTs) and specialty pharmaceuticals represent a radical shift in the treatment of rare diseases. For example, CGTs have revealed significant health benefits than formulated drugs for treating rare diseases. In the US, more than 900 investigational new drug (IND) applications targeting gene therapy products are underway. Also, 10-20 gene therapies are approved annually by the FDA. Likewise, in August 2022, the FDA approved Bluebird Bio's "Zynteglo (betibeglogene autotemcel)." It was the most expensive single-application drug approval in the US intended for the treatment of a rare neurological disorder-cerebral adrenoleukodystrophy (CALD).

Emergence of Automated Real?Time Flow Cytometry (ART?FCM)

Flow cytometry (FCM) and its technological possibilities have greatly advanced in the past decade as an analysis tool for single-cell properties and population distributions of different cell types in bioreactors. Along the way, a few automated real?time flow cytometry (ART?FCM) solutions were developed for monitoring bioreactor processes without operator interference over extended periods with a variable sampling frequency.

ART?FCM enables long?term measurements without missing any important events in bioprocesses and uncovers temporal phenomena that are likely unknown and should be investigated in greater detail. Also, more frequent measurements can be performed at a user-defined frequency, independent of the availability of personnel. When compared with methods such as omics that are only partially available on a single-cell level, multi-parameter measurements can be easily established without the extended effort of labor and time via ART-FCM.

Compared with conventional FCM studies, microfluidic devices great future potential as ART?FCM on a chip. In this context, parallelization might become more relevant, as samples from different bioreactors or different locations inside a bioreactor setup could be analyzed simultaneously. Many aspects might also be adapted to other experimental setups where fast and reproducible real?time monitoring of fluorescent process parameters is also of interest. In conclusion, ART?FCM will most probably advance exponentially in the upcoming years.

The COVID-19 pandemic had a positive impact on the bioprocess technology market. By mid-May, more than 215 novel and repurposed therapies were in the pipeline for the treatment of COVID-19, with rising investment from organizations such as the Coalition for Epidemic Preparedness Innovations and Melinda and Gates Foundation. Also, additional investments were made by the biopharmaceutical companies for commercial manufacturing. Amid the pandemic, the investment increased the adoption of bioprocessing technologies, enhancing efficiency and productivity at a large scale. Moreover, well-infrastructure facilities in regional markets were opened that will ultimately accelerate towards supply chain and bioprocessing facilities in the region.

Type-Based Insights

Based on type, the bioprocess technology market is segmented into cell culture media bioprocess, chromatography bioprocess, consumables & accessories, and others. The cell culture media bioprocess segment held a largest market share of bioprocess technology in 2022 whereas chromatography bioprocess is anticipated to register a highest CAGR during the forecast period (2023-2028).

Modality-Based Insights

Based on modality, the global bioprocess technology market is bifurcated into single use and multiple use. The single use segment accounted a larger market share for bioprocess technology in 2022. The multiple use segment is expected to grow at a higher CAGR during the forecast period.

End User-Based Insights

In terms of end user, the bioprocess technology market is categorized into academic & medical institutions, biopharmaceutical companies, research laboratories, and others. The biopharmaceutical companies segment held a largest market share in 2022, whereas academic & medical institutions is expected to register a higher CAGR during the forecast period.

Bioprocess Technology Market: Competitive Landscape and Key Developments

Merck KGaA, Sartorius AG, Thermo Fisher Scientific Inc, Corning Inc, STAMM Biotech, Lonza Group AG, Eppendorf SE, Repligen Corp, Danaher Corp, BioPharma Dynamics are among the key companies operating in the global bioprocess technology market. Leading players focus on expanding and diversifying their market presence and clientele, thereby tapping prevailing business opportunities.

In June 2022, Merck has entered a collaboration with Agilent Technologies to advance Process Analytical Technologies (PAT). PAT, which is strongly encouraged by global regulatory authorities, is a key enabler for real-time release and Bioprocessing 4.0.

In March 2020, Sartorius launched BIOSTAT STR Generation 3 single-use bioreactor and BIOBRAIN automation platform to introduce innovations that will change the field of biopharmaceutical process development and manufacturing. Biostat STR simplifies biologics production.

Reasons to Buy:

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the global bioprocess technology market.
• Highlights key business priorities in order to assist companies to realign their business strategies.
• The key findings and recommendations highlight crucial progressive industry trends in the global bioprocess technology market, thereby allowing players across the value chain to develop effective long-term strategies.
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
• Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
• Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Table Of Contents

1. Introduction

• 1.1 Scope of the Study
• 1.2 The Insight Partners Research Report Guidance
• 1.3 Market Segmentation
  • 1.3.1 Global Bioprocess Technology Market - by Type
  • 1.3.2 Global Bioprocess Technology Market - by Modality
  • 1.3.3 Global Bioprocess Technology Market - by End User
  • 1.3.4 Global Bioprocess Technology Market - by Geography

2. Bioprocess Technology Market - Key Takeaways

3. Research Methodology

• 3.1 Coverage
• 3.2 Secondary Research
• 3.3 Primary Research

4. Bioprocess Technology Market - Market Landscape

• 4.1 Overview
• 4.2 PEST Analysis
  • 4.2.1 North America PEST Analysis
  • 4.2.2 Europe PEST Analysis
  • 4.2.3 Asia Pacific PEST Analysis
  • 4.2.4 South & Central America PEST Analysis
  • 4.2.5 Middle East & Africa PEST Analysis
• 4.3 Expert's Opinion

5. Bioprocess Technology Market - Key Market Dynamics

• 5.1 Market Drivers
  • 5.1.1 Growing R&D Spendings to Introduce New Drug Compounds
  • 5.1.2 Increasing Prevalence of Chronic Diseases
• 5.2 Market Restraints
  • 5.2.1 Stringent Regulatory Policies
• 5.3 Market Opportunities
  • 5.3.1 Introducing Advanced Bioprocess Technologies
• 5.4 Future Trends
  • 5.4.1 Introduction of Automated Real?Time Flow Cytometry (ART?FCM)
• 5.5 Impact Analysis

6. Bioprocess Technology Market - Global Analysis

• 6.1 Global Bioprocess Technology Market Revenue Forecast and Analysis
• 6.2 Global Bioprocess Technology Market, by Geography - Forecast and Analysis
• 6.3 Market Positioning of Key Players

7. Global Bioprocess Technology Market - Revenue and Forecast to 2028 - by Type

• 7.1 Overview
• 7.2 Bioprocess Technology Market Revenue Share, by Type 2022 & 2028 (%)
• 7.3 Cell Culture Media Bioprocess
  • 7.3.1 Overview
  • 7.3.2 Cell Culture Media Bioprocess: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
• 7.4 Chromatographic Bioprocess
  • 7.4.1 Overview
  • 7.4.2 Chromatographic Bioprocess: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
• 7.5 Consumables & Accessories
  • 7.5.1 Overview
  • 7.5.2 Consumables & Accessories: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
• 7.6 Others
  • 7.6.1 Overview
  • 7.6.2 Others: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)

8. Global Bioprocess Technology Market Analysis and Forecasts to 2028 - by Modality

• 8.1 Overview
• 8.2 Global Bioprocess Technology Market, by Modality 2022 & 2028 (%)
• 8.3 Single Use
  • 8.3.1 Overview
  • 8.3.2 Single Use: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
• 8.4 Multiple Use
  • 8.4.1 Overview
  • 8.4.2 Multiple Use: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)

9. Global Bioprocess Technology Market - Revenue and Forecast to 2028 - by End User

• 9.1 Overview
• 9.2 Bioprocess Technology Market Revenue Share, by End User 2022 & 2028 (%)
• 9.3 Academic & Medical Institutions
  • 9.3.1 Overview
  • 9.3.2 Academic & Medical Institutions: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
• 9.4 Biopharmaceutical Companies
  • 9.4.1 Overview
  • 9.4.2 Biopharmaceutical Companies: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
• 9.5 Research Laboratories
  • 9.5.1 Overview
  • 9.5.2 Research Laboratories: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
• 9.6 Others
  • 9.6.1 Overview
  • 9.6.2 Others: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)

10. Bioprocess Technology Market - Revenue and Forecast to 2028 - Geographic Analysis

• 10.1 North America: Bioprocess Technology Market
  • 10.1.1 Overview
  • 10.1.2 North America: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • 10.1.3 North America: Bioprocess Technology Market, by Type, 2019-2028 (US$ Million)
  • 10.1.4 North America: Bioprocess Technology Market, by Modality, 2019-2028 (US$ Million)
  • 10.1.5 North America: Bioprocess Technology Market, by End User, 2019-2028 (US$ Million)
    • 10.1.5.1 US: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
      • 10.1.5.1.1 Overview
      • 10.1.5.1.2 US: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
      • 10.1.5.1.3 US: Bioprocess Technology Market, by Type, 2019-2028 (US$ Million)
      • 10.1.5.1.4 US: Bioprocess Technology Market, by Modality, 2019-2028 (US$ Million)
      • 10.1.5.1.5 US: Bioprocess Technology Market, by End User, 2019-2028 (US$ Million)
    • 10.1.5.2 Canada: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
      • 10.1.5.2.1 Overview
      • 10.1.5.2.2 Canada: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
      • 10.1.5.2.3 Canada: Bioprocess Technology Market, by Type, 2019-2028 (US$ Million)
      • 10.1.5.2.4 Canada: Bioprocess Technology Market, by Modality, 2019-2028 (US$ Million)
      • 10.1.5.2.5 Canada: Bioprocess Technology Market, by End User, 2019-2028 (US$ Million)
    • 10.1.5.3 Mexico: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
      • 10.1.5.3.1 Overview
      • 10.1.5.3.2 Mexico: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
      • 10.1.5.3.3 Mexico: Bioprocess Technology Market, by Type, 2019-2028 (US$ Million)
      • 10.1.5.3.4 Mexico: Bioprocess Technology Market, by Modality, 2019-2028 (US$ Million)
      • 10.1.5.3.5 Mexico: Bioprocess Technology Market, by End User, 2019-2028 (US$ Million)
• 10.2 Europe: Bioprocess Technology Market
  • 10.2.1 Overview
  • 10.2.2 Europe: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • 10.2.3 Europe: Bioprocess Technology Market, by Type, 2019-2028 (US$ Million)
  • 10.2.4 Europe: Bioprocess Technology Market, by Modality, 2019-2028 (US$ Million)
  • 10.2.5 Europe: Bioprocess Technology Market, by End User, 2019-2028 (US$ Million)
  • 10.2.6 Europe: Bioprocess Technology Market, by Country, 2022 & 2028 (%)
    • 10.2.6.1 Germany: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
      • 10.2.6.1.1 Overview
      • 10.2.6.1.2 Germany: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
      • 10.2.6.1.3 Germany: Bioprocess Technology Market, by Type, 2019-2028 (US$ Million)
      • 10.2.6.1.4 Germany: Bioprocess Technology Market, by Modality, 2019-2028 (US$ Million)
      • 10.2.6.1.5 Germany: Bioprocess Technology Market, by End User, 2019-2028 (US$ Million)
    • 10.2.6.2 UK: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
      • 10.2.6.2.1 Overview
      • 10.2.6.2.2 UK: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
      • 10.2.6.2.3 UK: Bioprocess Technology Market, by Type, 2019-2028 (US$ Million)
      • 10.2.6.2.4 UK: Bioprocess Technology Market, by Modality, 2019-2028 (US$ Million)
      • 10.2.6.2.5 UK: Bioprocess Technology Market, by End User, 2019-2028 (US$ Million)
    • 10.2.6.3 France: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
      • 10.2.6.3.1 Overview
      • 10.2.6.3.2 France: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
      • 10.2.6.3.3 France: Bioprocess Technology Market, by Type, 2019-2028 (US$ Million)
      • 10.2.6.3.4 France: Bioprocess Technology Market, by Modality, 2019-2028 (US$ Million)
      • 10.2.6.3.5 France: Bioprocess Technology Market, by End User, 2019-2028 (US$ Million)
    • 10.2.6.4 Italy: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
      • 10.2.6.4.1 Overview
      • 10.2.6.4.2 Italy: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
      • 10.2.6.4.3 Italy: Bioprocess Technology Market, by Type, 2019-2028 (US$ Million)
      • 10.2.6.4.4 Italy: Bioprocess Technology Market, by Modality, 2019-2028 (US$ Million)
      • 10.2.6.4.5 Italy: Bioprocess Technology Market, by End User, 2019-2028 (US$ Million)
    • 10.2.6.5 Spain: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
      • 10.2.6.5.1 Overview
      • 10.2.6.5.2 Spain: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
      • 10.2.6.5.3 Spain: Bioprocess Technology Market, by Type, 2019-2028 (US$ Million)
      • 10.2.6.5.4 Spain: Bioprocess Technology Market, by Modality, 2019-2028 (US$ Million)
      • 10.2.6.5.5 Spain: Bioprocess Technology Market, by End User, 2019-2028 (US$ Million)
    • 10.2.6.6 Rest of Europe: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
      • 10.2.6.6.1 Overview
      • 10.2.6.6.2 Rest of Europe: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
      • 10.2.6.6.3 Rest of Europe: Bioprocess Technology Market, by Type, 2019-2028 (US$ Million)
      • 10.2.6.6.4 Rest of Europe: Bioprocess Technology Market, by Modality, 2019-2028 (US$ Million)
      • 10.2.6.6.5 Rest of Europe: Bioprocess Technology Market, by End User, 2019-2028 (US$ Million)
• 10.3 Asia Pacific: Bioprocess Technology Market
  • 10.3.1 Overview
  • 10.3.2 Asia Pacific: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • 10.3.3 Asia Pacific: Bioprocess Technology Market, by Type, 2019-2028 (US$ Million)
  • 10.3.4 Asia Pacific: Bioprocess Technology Market, by Modality, 2019-2028 (US$ Million)
  • 10.3.5 Asia Pacific: Bioprocess Technology Market, by End User, 2019-2028 (US$ Million)
  • 10.3.6 Asia Pacific: Bioprocess Technology Market, by Country, 2022 & 2028 (%)
    • 10.3.6.1 China: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
      • 10.3.6.1.1 Overview
      • 10.3.6.1.2 China: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
      • 10.3.6.1.3 China: Bioprocess Technology Market, by Type, 2019-2028 (US$ Million)
      • 10.3.6.1.4 China: Bioprocess Technology Market, by Modality, 2019-2028 (US$ Million)
      • 10.3.6.1.5 China Bioprocess Technology Market, by End User, 2019-2028 (US$ Million)
    • 10.3.6.2 Japan: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
      • 10.3.6.2.1 Overview
      • 10.3.6.2.2 Japan: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
      • 10.3.6.2.3 Japan: Bioprocess Technology Market, by Type, 2019-2028 (US$ Million)
      • 10.3.6.2.4 Japan: Bioprocess Technology Market, by Modality, 2019-2028 (US$ Million)
      • 10.3.6.2.5 Japan: Bioprocess Technology Market, by End User, 2019-2028 (US$ Million)
    • 10.3.6.3 India: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
      • 10.3.6.3.1 Overview
      • 10.3.6.3.2 India: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
      • 10.3.6.3.3 India: Bioprocess Technology Market, by Type, 2019-2028 (US$ Million)
      • 10.3.6.3.4 India: Bioprocess Technology Market, by Modality, 2019-2028 (US$ Million)
      • 10.3.6.3.5 India: Bioprocess Technology Market, by End User, 2019-2028 (US$ Million)
    • 10.3.6.4 South Korea: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
      • 10.3.6.4.1 Overview
      • 10.3.6.4.2 South Korea: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
      • 10.3.6.4.3 South Korea: Bioprocess Technology Market, by Type, 2019-2028 (US$ Million)
      • 10.3.6.4.4 South Korea: Bioprocess Technology Market, by Modality, 2019-2028 (US$ Million)
      • 10.3.6.4.5 South Korea: Bioprocess Technology Market, by End User, 2019-2028 (US$ Million)
    • 10.3.6.5 Australia: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
      • 10.3.6.5.1 Overview
      • 10.3.6.5.2 Australia: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
      • 10.3.6.5.3 Australia: Bioprocess Technology Market, by Type, 2019-2028 (US$ Million)
      • 10.3.6.5.4 Australia: Bioprocess Technology Market, by Modality, 2019-2028 (US$ Million)
      • 10.3.6.5.5 Australia: Bioprocess Technology Market, by End User, 2019-2028 (US$ Million)
    • 10.3.6.6 Rest of Asia Pacific: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
      • 10.3.6.6.1 Overview
      • 10.3.6.6.2 Rest of Asia Pacific: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
      • 10.3.6.6.3 Rest of Asia Pacific: Bioprocess Technology Market, by Type, 2019-2028 (US$ Million)
      • 10.3.6.6.4 Rest of Asia Pacific: Bioprocess Technology Market, by Modality, 2019-2028 (US$ Million)
      • 10.3.6.6.5 Rest of Asia Pacific: Bioprocess Technology Market, by End User, 2019-2028 (US$ Million)
• 10.4 Middle East & Africa Bioprocess Technology Market
  • 10.4.1 Overview
  • 10.4.2 Middle East & Africa: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • 10.4.3 Middle East & Africa: Bioprocess Technology Market, by Type, 2019-2028 (US$ Million)
  • 10.4.4 Middle East & Africa: Bioprocess Technology Market, by Modality, 2019-2028 (US$ Million)
  • 10.4.5 Middle East & Africa Bioprocess Technology Market, by End User, 2019-2028 (US$ Million)
  • 10.4.6 Middle East & Africa: Bioprocess Technology Market, by Country, 2022 & 2028 (%)
    • 10.4.6.1 UAE: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
      • 10.4.6.1.1 Overview
      • 10.4.6.1.2 UAE: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
      • 10.4.6.1.3 UAE: Bioprocess Technology Market, by Type, 2019-2028 (US$ Million)
      • 10.4.6.1.4 UAE: Bioprocess Technology Market, by Modality, 2019-2028 (US$ Million)
      • 10.4.6.1.5 UAE Bioprocess Technology Market, by End User, 2019-2028 (US$ Million)
    • 10.4.6.2 Saudi Arabia: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
      • 10.4.6.2.1 Overview
      • 10.4.6.2.2 Saudi Arabia: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
      • 10.4.6.2.3 Saudi Arabia: Bioprocess Technology Market, by Type, 2019-2028 (US$ Million)
      • 10.4.6.2.4 Saudi Arabia: Bioprocess Technology Market, by Modality, 2019-2028 (US$ Million)
      • 10.4.6.2.5 Saudi Arabia Bioprocess Technology Market, by End User, 2019-2028 (US$ Million)
    • 10.4.6.3 South Africa: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
      • 10.4.6.3.1 Overview
      • 10.4.6.3.2 South Africa: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
      • 10.4.6.3.3 South Africa: Bioprocess Technology Market, by Type, 2019-2028 (US$ Million)
      • 10.4.6.3.4 South Africa: Bioprocess Technology Market, by Modality, 2019-2028 (US$ Million)
      • 10.4.6.3.5 South Africa Bioprocess Technology Market, by End User, 2019-2028 (US$ Million)
    • 10.4.6.4 Rest of Middle East & Africa: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
      • 10.4.6.4.1 Overview
      • 10.4.6.4.2 Rest of Middle East & Africa: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
      • 10.4.6.4.3 Rest of Middle East & Africa: Bioprocess Technology Market, by Type, 2019-2028 (US$ Million)
      • 10.4.6.4.4 Rest of Middle East & Africa: Bioprocess Technology Market, by Modality, 2019-2028 (US$ Million)
      • 10.4.6.4.5 Rest of Middle East & Africa Bioprocess Technology Market, by End User, 2019-2028 (US$ Million)
• 10.5 South & Central America Bioprocess Technology Market
  • 10.5.1 Overview
  • 10.5.2 South & Central America: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • 10.5.3 South & Central America: Bioprocess Technology Market, by Type, 2019-2028 (US$ Million)
  • 10.5.4 South & Central America: Bioprocess Technology Market, by Modality, 2019-2028 (US$ Million)
  • 10.5.5 South & Central America: Bioprocess Technology Market, by End User, 2019-2028 (US$ Million)
  • 10.5.6 South & Central America: Bioprocess Technology Market, by Country, 2022 & 2028 (%)
    • 10.5.6.1 Brazil: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
      • 10.5.6.1.1 Overview
      • 10.5.6.1.2 Brazil: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
      • 10.5.6.1.3 Brazil: Bioprocess Technology Market, by Type, 2019-2028 (US$ Million)
      • 10.5.6.1.4 Brazil: Bioprocess Technology Market, by Modality, 2019-2028 (US$ Million)
      • 10.5.6.1.5 Brazil: Bioprocess Technology Market, by End User, 2019-2028 (US$ Million)
    • 10.5.6.2 Argentina: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
      • 10.5.6.2.1 Overview
      • 10.5.6.2.2 Argentina: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
      • 10.5.6.2.3 Argentina: Bioprocess Technology Market, by Type, 2019-2028 (US$ Million)
      • 10.5.6.2.4 Argentina: Bioprocess Technology Market, by Modality, 2019-2028 (US$ Million)
      • 10.5.6.2.5 Argentina: Bioprocess Technology Market, by End User, 2019-2028 (US$ Million)
    • 10.5.6.3 Rest of South & Central America: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
      • 10.5.6.3.1 Overview
      • 10.5.6.3.2 Rest of South & Central America: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
      • 10.5.6.3.3 Rest of South & Central America: Bioprocess Technology Market, by Type, 2019-2028 (US$ Million)
      • 10.5.6.3.4 Rest of South & Central America: Bioprocess Technology Market, by Modality, 2019-2028 (US$ Million)
      • 10.5.6.3.5 Rest of South & Central America: Bioprocess Technology Market, by End User, 2019-2028 (US$ Million)

11. Impact Of COVID-19 Pandemic on Bioprocess Technology Market

• 11.1 North America: Impact Assessment of COVID-19 Pandemic
• 11.2 Europe: Impact Assessment of COVID-19 Pandemic
• 11.3 Asia Pacific: Impact Assessment of COVID-19 Pandemic
• 11.4 Middle East & Africa: Impact Assessment of COVID-19 Pandemic
• 11.5 South & Central America: Impact Assessment of COVID-19 Pandemic

12. Bioprocess Technology Market - Industry Landscape

• 12.1 Overview
• 12.2 Growth Strategies in Bioprocess Technology Market
• 12.3 Organic Growth Strategies
  • 12.3.1 Overview
• 12.4 Inorganic Growth Strategies
  • 12.4.1 Overview

13. Company Profiles

• 13.1 Merck KGaA
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
• 13.2 Sartorius AG
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
• 13.3 Thermo Fisher Scientific Inc
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
• 13.4 Corning Inc
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
• 13.5 STAMM Biotech
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
• 13.6 Lonza Group AG
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
• 13.7 Eppendorf SE
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments
• 13.8 Repligen Corp
  • 13.8.1 Key Facts
  • 13.8.2 Business Description
  • 13.8.3 Products and Services
  • 13.8.4 Financial Overview
  • 13.8.5 SWOT Analysis
  • 13.8.6 Key Developments
• 13.9 Danaher Corp
  • 13.9.1 Key Facts
  • 13.9.2 Business Description
  • 13.9.3 Products and Services
  • 13.9.4 Financial Overview
  • 13.9.5 SWOT Analysis
  • 13.9.6 Key Developments
• 13.10 BioPharma Dynamics Ltd
  • 13.10.1 Key Facts
  • 13.10.2 Business Description
  • 13.10.3 Products and Services
  • 13.10.4 Financial Overview
  • 13.10.5 SWOT Analysis
  • 13.10.6 Key Developments

14. Appendix

• 14.1 About The Insight Partners
• 14.2 Glossary of Terms